Percutaneous closure of patent foramen ovale for cryptogenic stroke: A meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 168, Issue 4, 2013, Pages 4132-4138

  Kwong, Joey S W ^a   Lam, Yat Yin ^a   Yu, Cheuk Man ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cryptogenic stroke; Meta analysis; Patent foramen ovale; Percutaneous transcatheter closure; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CLOPIDOGREL; DIPYRIDAMOLE; TICLOPIDINE; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; HEART ATRIUM FIBRILLATION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; META ANALYSIS; MORTALITY; PATENT FORAMEN OVALE; PERCUTANEOUS TRANSCATHETER CLOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SEPTAL OCCLUDER; TRANSIENT ISCHEMIC ATTACK; FORAMEN OVALE, PATENT; PROCEDURES; STROKE; TREATMENT OUTCOME;

FORAMEN OVALE, PATENT; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPTAL OCCLUDER DEVICE; STROKE; TREATMENT OUTCOME;

EID: 84886288217     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.077     Document Type: Article

References (45)

1. A.S. Go, D. Mozaffarian, and V.L. Roger Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. R.L. Sacco, J.H. Ellenberg, and J.P. Mohr Infarcts of undetermined cause: the NINCDS Stroke Data Bank Ann Neurol 25 1989 382 390
3. F. Guercini, M. Acciarresi, G. Agnelli, and M. Paciaroni Cryptogenic stroke: time to determine aetiology J Thromb Haemost 6 2008 549 554
4. H. Hara, R. Virmani, and E. Ladich Patent foramen ovale: current pathology, pathophysiology, and clinical status J Am Coll Cardiol 46 2005 1768 1776
5. P.A. Calvert, B.S. Rana, A.C. Kydd, and L.M. Shapiro Patent foramen ovale: anatomy, outcomes, and closure Nat Rev Cardiol 8 2011 148 160
6. S. Kutty, P.P. Sengupta, and B.K. Khandheria Patent foramen ovale: the known and the to be known J Am Coll Cardiol 59 2012 1665 1671
7. B.A. Maron, P.S. Shekar, and S.Z. Goldhaber Paradoxical embolism Circulation 122 2010 1968 1972
8. P. Lechat, J.L. Mas, and G. Lascault Prevalence of patent foramen ovale in patients with stroke N Engl J Med 318 1988 1148 1152
9. M. Di Tullio, R.L. Sacco, A. Gopal, J.P. Mohr, and S. Homma Patent foramen ovale as a risk factor for cryptogenic stroke Ann Intern Med 117 1992 461 465
10. S. Homma, and R.L. Sacco Patent foramen ovale and stroke Circulation 112 2005 1063 1072
11. M. Handke, A. Harloff, M. Olschewski, A. Hetzel, and A. Geibel Patent foramen ovale and cryptogenic stroke in older patients N Engl J Med 357 2007 2262 2268
12. B. Meier, B. Frank, A. Wahl, and H.C. Diener Secondary stroke prevention: patent foramen ovale, aortic plaque, and carotid stenosis Eur Heart J 33 2012 705 713
13. I. Cruz-González, J. Solis, T.J. Kiernan, B.P. Yan, Y.Y. Lam, and I.F. Palacios Clinical manifestation and current management of patent foramen ovale Expert Rev Cardiovasc Ther 7 2009 1011 1022
14. P. Khairy, C.P. O'Donnell, and M.J. Landzberg Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review Ann Intern Med 139 2003 753 760
15. G.D. Kitsios, I.J. Dahabreh, A.M. Abu Dabrh, D.E. Thaler, and D.M. Kent Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence Stroke 43 2012 422 431
16. S. Agarwal, N.S. Bajaj, D.J. Kumbhani, E.M. Tuzcu, and S.R. Kapadia Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism JACC Cardiovasc Interv 5 2012 777 789
17. J.P.T. Higgins, and S. Green Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011 The Cochrane Collaboration [ www.cochrane-handbook.org (accessed 15 April 2013)]
18. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 2009 e1000097
19. A.J. Furlan, M. Reisman, and J. Massaro Closure or medical therapy for cryptogenic stroke with patent foramen ovale N Engl J Med 366 2012 991 999
20. A.J. Furlan, M. Reisman, and J. Massaro Study design of the CLOSURE I Trial: a prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the STARFlex septal closure system versus best medical therapy in patients with stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale Stroke 41 2010 2872 2883
21. B. Meier, B. Kalesan, and H.P. Mattle Percutaneous closure of patent foramen ovale in cryptogenic embolism N Engl J Med 368 2013 1083 1091
22. A.A. Khattab, S. Windecker, and P. Jüni Randomized clinical trial comparing percutaneous closure of patent foramen ovale (PFO) using the Amplatzer PFO Occluder with medical treatment in patients with cryptogenic embolism (PC-Trial): rationale and design Trials 12 2011 56
23. J.D. Carroll, J.L. Saver, and D.E. Thaler Closure of patent foramen ovale versus medical therapy after cryptogenic stroke N Engl J Med 368 2013 1092 1100
24. NCT00562289 Patent foramen ovale closure or anticoagulants versus antiplatelet therapy to prevent stroke recurrence (CLOSE) http://clinicaltrials. gov/ct2/show/NCT00562289 [accessed 10 April 2013]
25. NCT01550588 Device closure versus medical therapy for cryptogenic stroke patients with high-risk patent foramen ovale (DEFENSE-PFO) http:// clinicaltrials.gov/show/NCT01550588 [accessed 10 April 2013]
26. NCT00738894 GORE HELEX™ septal occluder for patent foramen ovale (PFO) closure in stroke patients - the Gore REDUCE clinical study (HLX 06-03) http://clinicaltrials.gov/ct2/show/NCT00738894 [accessed 10 April 2013]
27. D.E. Thaler, and A. Wahl Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth? Stroke 43 2012 3147 3149
28. K.L. Furie, S.E. Kasner, and R.J. Adams Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 42 2011 227 276
29. J.D. Easton, J.L. Saver, and G.W. Albers Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease Stroke 40 2009 2276 2293
30. J. Alaeddini, G. Feghali, S. Jenkins, S. Ramee, C. White, and F. Abi-Samra Frequency of atrial tachyarrhythmias following transcatheter closure of patent foramen ovale J Invasive Cardiol 18 2006 365 368
31. A. Burow, M. Schwerzmann, and D. Wallmann Atrial fibrillation following device closure of patent foramen ovale Cardiology 111 2008 47 50
32. M. Taaffe, E. Fischer, and A. Baranowski Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder) Am J Cardiol 101 2008 1353 1358
33. I. Ferreira-González, J.W. Busse, and D. Heels-Ansdell Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials BMJ 334 2007 786
34. D.M. Kent, and D.E. Thaler Is patent foramen ovale a modifiable risk factor for stroke recurrence? Stroke 41 10 Suppl. 2010 S26 S30
35. J.L. Mas, and M. Zuber Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm Am Heart J 130 1995 1083 1088
36. J.L. Mas, C. Arquizan, and C. Lamy Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both N Engl J Med 345 2001 1740 1746
37. S. Homma, R.L. Sacco, M.R. Di Tullio, R.R. Sciacca, J.P. Mohr, and PFO in Cryptogenic Stroke Study (PICSS) Investigators Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study Circulation 105 2002 2625 2631
38. M.A. Almekhlafi, S.B. Wilton, D.M. Rabi, W.A. Ghali, D.L. Lorenzetti, and M.D. Hill Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis Neurology 73 2009 89 97
39. B. Meier Closure of patent foramen ovale: technique, pitfalls, complications, and follow up Heart 91 2005 444 448
40. M. Schwerzmann, and O. Salehian Hazards of percutaneous PFO closure Eur J Echocardiogr 6 2005 393 395
41. A. Abaci, S. Unlu, Y. Alsancak, U. Kaya, and B. Sezenoz Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies Catheter Cardiovasc Interv Feb 14 2013 10.1002/ccd.24875
42. D.M. Kent, D.E. Thaler, and RoPE Study Investigators The Risk of Paradoxical Embolism (RoPE) study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke Trials 12 2011 185
43. J. Bogousslavsky, S. Garazi, X. Jeanrenaud, N. Aebischer, and G. Van Melle Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group Neurology 46 1996 1301 1305
44. P.T. O'Gara, S.R. Messe, E.M. Tuzcu, G. Catha, and J.C. Ring Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation J Am Coll Cardiol 53 2009 2014 2018
45. J. Tobis, and M. Shenoda Percutaneous treatment of patent foramen ovale and atrial septal defects J Am Coll Cardiol 60 2012 1722 1732